3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
OTHER
7
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
495
Neoplasms
301
Breast Neoplasms
298
Colorectal Neoplasms
229
Neoplasm Metastasis
194
Prostatic Neoplasms
174
Ovarian Neoplasms
173
Multiple Myeloma
158
Lung Neoplasms
157
Recurrence
134
Melanoma
121
Pancreatic Neoplasms
116
Squamous Cell Carcinoma of Head and Neck
105
Stomach Neoplasms
101
Leukemia, Myeloid, Acute
101
Endometrial Neoplasms
101
Small Cell Lung Carcinoma
88
Leukemia, Lymphocytic, Chronic, B-Cell
86
Triple Negative Breast Neoplasms
85
Lymphoma, Non-Hodgkin
85
Carcinoma, Renal Cell
82
Carcinoma, Hepatocellular
79
Urinary Bladder Neoplasms
77
Lymphoma, Large B-Cell, Diffuse
74
Lymphoma, Follicular
67
Advanced Solid Tumors
66
Parkinson Disease 4, Autosomal Dominant Lewy Body
62
Lymphoma
61
Glioblastoma
58
Head and Neck Neoplasms
56
Interventions
Observation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Lung Diseases, Interstitial
×
90 days
×
Clear all
NCT06192004
2026-05-04
LOOP
AstraZeneca
Terminated
83 enrolled